Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study - Bourrier, A; Carrat, F; Colombel, J F (Aliment Pharmacol Ther, 2016)
, et al; CESAME Study Group.